Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-07-19
2010-12-07
Pryor, Alton N (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07846924
ABSTRACT:
This invention provides a progesterone receptor antagonist of formula 1 having the structurewherein, T is O, S, or absent; R1, and R2are each, independently, hydrogen, alkyl, substituted alkyl; or R1and R2are taken together form a ring and together contain —CH2(CH2)nCH2—, —CH2CH2CMe2CH2CH2—, —O(CH2)pCH2—, —O(CH2)qO—, —CH2CH2OCH2CH2—, or —CH2CH2NR7CH2CH2—; n=1-5; p=1-4; q=1-4; R3is hydrogen, OH, NH2, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, or CORA; RAis hydrogen, alkyl, substituted alkyl, alkoxy, substituted alkoxy, aminoalkyl, or substituted aminoalkyl; R4is hydrogen, halogen, CN, NH2, alkyl, substituted alkyl, alkoxy, substituted alkoxy, aminoalkyl, or substituted aminoalkyl; R5is hydrogen, alkyl, or substituted alkyl; R6is hydrogen, alkyl, substituted alkyl, or CORB; RBis hydrogen, alkyl, substituted alkyl, alkoxy, substituted alkoxy, aminoalkyl, or substituted aminoalkyl; R7is hydrogen or alkyl; or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 3635964 (1972-01-01), Skorcz
patent: 3917592 (1975-11-01), Kobzina
patent: 4093730 (1978-06-01), Butti
patent: 4258185 (1981-03-01), Nakao et al.
patent: 4440785 (1984-04-01), Walsh
patent: 4666913 (1987-05-01), Kubla et al.
patent: 4670566 (1987-06-01), Walsh
patent: 4721721 (1988-01-01), Kuhla
patent: 4822794 (1989-04-01), Spada
patent: 4831027 (1989-05-01), Narr
patent: 4853473 (1989-08-01), Fischer
patent: 4933336 (1990-06-01), Martin et al.
patent: 5007952 (1991-04-01), Kume
patent: 5171851 (1992-12-01), Kim
patent: 5414088 (1995-05-01), von der Saal
patent: 5453516 (1995-09-01), Fischer
patent: 5475020 (1995-12-01), Johnson
patent: 5521166 (1996-05-01), Grubb
patent: 5681817 (1997-10-01), Hodgen
patent: 5688808 (1997-11-01), Jones
patent: 5688810 (1997-11-01), Jones
patent: 5693646 (1997-12-01), Jones
patent: 5693647 (1997-12-01), Jones
patent: 5696127 (1997-12-01), Jones
patent: 5696130 (1997-12-01), Jones
patent: 5696133 (1997-12-01), Jones
patent: 5719136 (1998-02-01), Chwalisz
patent: 5733902 (1998-03-01), Schneider
patent: 5808139 (1998-09-01), Pathirana
patent: 5874430 (1999-02-01), Christ
patent: 6077840 (2000-06-01), Kurihara
patent: 6306851 (2001-10-01), Santilli
patent: 6319912 (2001-11-01), Grubb
patent: 6329416 (2001-12-01), Grubb
patent: 6339098 (2002-01-01), Collins
patent: 6355648 (2002-03-01), Fensome
patent: 6358947 (2002-03-01), Zhi et al.
patent: 6358948 (2002-03-01), Zhang et al.
patent: 6362237 (2002-03-01), Chwalisz et al.
patent: 6369056 (2002-04-01), Zhang et al.
patent: 6380178 (2002-04-01), Grubb et al.
patent: 6380235 (2002-04-01), Zhang et al.
patent: 6391907 (2002-05-01), Fensome et al.
patent: 6399593 (2002-06-01), Grubb et al.
patent: 6407101 (2002-06-01), Collins et al.
patent: 6417214 (2002-07-01), Ullrich et al.
patent: 6423699 (2002-07-01), Grubb et al.
patent: 6436929 (2002-08-01), Zhang et al.
patent: 6441019 (2002-08-01), Santilli et al.
patent: 6444668 (2002-09-01), Grubb et al.
patent: 6462032 (2002-10-01), Grubb et al.
patent: 6498154 (2002-12-01), Grubb et al.
patent: 6503939 (2003-01-01), Grubb et al.
patent: 6509334 (2003-01-01), Zhang et al.
patent: 6521657 (2003-02-01), Fensome et al.
patent: 6544970 (2003-04-01), Grubb et al.
patent: 6562857 (2003-05-01), Collins et al.
patent: 6566358 (2003-05-01), Zhang et al.
patent: 6566372 (2003-05-01), West et al.
patent: 6583145 (2003-06-01), Fensome et al.
patent: 6608068 (2003-08-01), Fensome et al.
patent: 6693103 (2004-02-01), Zhang et al.
patent: 6713478 (2004-03-01), Zhang et al.
patent: 6759408 (2004-07-01), Grubb et al.
patent: 6794373 (2004-09-01), Grubb et al.
patent: 6835744 (2004-12-01), Zhi et al.
patent: 6841568 (2005-01-01), Fensome et al.
patent: 6946454 (2005-09-01), Fensome et al.
patent: 6982261 (2006-01-01), Collins et al.
patent: 2002/0094983 (2002-07-01), Zhang et al.
patent: 2002/0111355 (2002-08-01), Zhang et al.
patent: 2002/0115853 (2002-08-01), Zhang et al.
patent: 2002/0169198 (2002-11-01), Fensome et al.
patent: 2003/0087925 (2003-05-01), O'Neill et al.
patent: 2003/0092711 (2003-05-01), Zhang et al.
patent: 2003/0130505 (2003-07-01), Zhi et al.
patent: 2003/0158182 (2003-08-01), Collins et al.
patent: 2003/0220388 (2003-11-01), Fensome et al.
patent: 2004/0002535 (2004-01-01), Fensome et al.
patent: 2004/0006060 (2004-01-01), Fensome et al.
patent: 2004/0006122 (2004-01-01), Fensome et al.
patent: 2004/0014798 (2004-01-01), Fensome et al.
patent: 2004/0152719 (2004-08-01), He et al.
patent: 2004/0152755 (2004-08-01), He et al.
patent: 2004/0186101 (2004-09-01), Zhang et al.
patent: 2005/0054711 (2005-03-01), Fensome et al.
patent: 2005/0171186 (2005-08-01), Fensome et al.
patent: 2006/0009509 (2006-01-01), Grubb et al.
patent: 2006/0030615 (2006-02-01), Fensome et al.
patent: 2006/0030717 (2006-02-01), Fensome et al.
patent: 3633861 (1988-04-01), None
patent: 4330234 (1995-03-01), None
patent: 4344463 (1995-06-01), None
patent: 022317 (1981-01-01), None
patent: 208510 (1987-01-01), None
patent: 311135 (1989-04-01), None
patent: 385850 (1990-09-01), None
patent: 483077 (1991-09-01), None
patent: 454330 (1991-10-01), None
patent: 535529 (1992-09-01), None
patent: 510235 (1992-10-01), None
patent: 947507 (1999-10-01), None
patent: 978279 (2000-02-01), None
patent: 63-112584 (1988-05-01), None
patent: WO-86/03749 (1986-07-01), None
patent: WO-91/06545 (1986-07-01), None
patent: WO-91/04974 (1991-04-01), None
patent: WO-91/06545 (1991-05-01), None
patent: WO-93/12085 (1993-06-01), None
patent: WO-94/14434 (1994-07-01), None
patent: WO-94/29272 (1994-12-01), None
patent: WO-9520389 (1995-02-01), None
patent: WO-95/11013 (1995-04-01), None
patent: WO-95/20389 (1995-08-01), None
patent: WO-95/20972 (1995-08-01), None
patent: WO-95/33746 (1995-12-01), None
patent: WO-96/15794 (1996-05-01), None
patent: WO-96/19458 (1996-06-01), None
patent: WO-96/19997 (1996-07-01), None
patent: WO-97/13767 (1997-04-01), None
patent: WO-97/49407 (1997-12-01), None
patent: WO-98/10765 (1998-03-01), None
patent: WO-98/14436 (1998-04-01), None
patent: WO-98/27059 (1998-06-01), None
patent: WO-9814436 (1998-06-01), None
patent: WO-98/55116 (1998-12-01), None
patent: WO-99/11264 (1999-03-01), None
patent: WO-99/1032503 (1999-03-01), None
patent: WO-99/15500 (1999-04-01), None
patent: WO-99/44608 (1999-09-01), None
patent: WO-01/15108 (2001-03-01), None
patent: WO-01/77100 (2001-10-01), None
patent: WO-2004937247 (2004-05-01), None
Winneker et al. (Nonsteroidal Progesterone Receptor Modulators: Structure Activity Relationships, Seminars in Reproductive Medicine, (Feb. 2005). 23(1):46.
Collins et al. (Novel pyrrole-containing progesterone receptor modulators, Bioorganic & Medicinal Chemistry Letters (2004), vol. 14, pp. 2185-2189.
Winneker et al., A new generation of progesterone receptor modulators, Steroids, 2008, vol. 73, pp. 689-701.
R. Evans, “The Steroid and Thyroid Hormone Receptor Superfamily”, Science, 240:889 (May 13, 1988).
A. Ulmann et al, “Clinical Uses of Mifepristone (MFP)”, Ann. N.Y. Acad. Sci., 261:248 (Jun. 12, 1995).
R. Kekkonen et al, “Sequential Regiment of the Antiprogesterone RU486 and Synthetic Progestin for Contraception”, Fertility and Sterility, 60(4):610 (Oct. 1993).
K. Horwitz et al, “Progestin, Progesterone Receptors, and Breast Cancer”, Horm. Cancer, publisher: Birkhaeuser, Boston, Mass., ed. Vedeckis, pp. 283-306 (1996) (abstract).
A. Murphy et al, “Regression of Uterine Leiomyomata in Response to the Antiprogesterone RU486”, J. Clin. Endo. Metab., 76(2):513 (Feb. 1993).
L. Kettel et al, “Endocrine Responses to Long-Term Administration of the Antiprogesterone RU486 in Patients with Pelvic Endometriosis”, Fertility and Sterility, 56(3):402 (Sep. 1991).
H. Michna et al, “Differentiation Therapy with Progesterone Antagonists”, Ann. N.Y. Acad. Sci., 761:224 (Jun. 1995).
L. Zhi et al, “5-Ary1-1,2-Dihydrochromeno[3,4-f]quinolines: A Novel Class of Nonsteroidal Human
Collins Mark A.
Edwards James P.
Jones Todd K.
Mackner Valerie A.
Tegley Christopher M.
Howson & Howson LLP
Pryor Alton N
Wyeth LLC
LandOfFree
Cyanopyrroles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyanopyrroles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyanopyrroles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4200482